Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107466 · ClinicalTrials.gov registry record
Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss
A clinical trial of Hearing Loss and Sensorineural Hearing Loss, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05107466 is a study of Hearing Loss and Sensorineural Hearing Loss that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 100 participants, below the 6,119-participant average among 58 other Hearing Loss trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05107466, a study of Hearing Loss and Sensorineural Hearing Loss, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to determine whether a test that measures a "Visual Evoked Potential" can be used in a new way for individuals that have hearing loss. This test measures the participant's brain's response (so called "brain waves") to specific visual images. This study will help the investigators determine whether this test could be used to improve treatments for patients with hearing loss. The "Visual Evoked Potential" measurement test is already used in the investigator's Neurology clinic at Dartmouth Hitchcock Medical Center for various conditions to measure "early" brain responses that occur in the first 1-2 seconds after a new cue. Our research aims to explore your brain's response just after that early 1-2 second period by looking at a specific response called the "P300". The P300 wave is a brain response to new or different images or sounds. A visual evoked P300 has not been studied in individuals with hearing loss. The investigators will compare the results of this test to standard auditory tests, tests of cognitive function, and cochlear implant patient outcomes to explore how these factors can predict successful use of a hearing aid or cochlear implant.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST P300 Visually evoked potential
Study Locations (1)
New Hampshire
- Dartmouth Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-07-28 |
| Est. Completion | 2026-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05107466
The ClinicalTrials.gov registry entry for NCT05107466 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,119-participant average among 58 other Hearing Loss trials with a reported enrollment target (98% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which P300 Visually evoked potential is the first listed.
NCT05107466 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05107466 about?
NCT05107466 is a clinical study titled "Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss". This research is being done to determine whether a test that measures a "Visual Evoked Potential" can be used in a new way for individuals that have hearing loss. This test measures the participant's brain's response (so called "brain waves") to specific visual images. This study will help the inves...
What is the current status of trial NCT05107466?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-07-28. Estimated completion is 2026-10-01.
What conditions does trial NCT05107466 study?
This clinical trial studies the following conditions: Hearing Loss, Sensorineural Hearing Loss.
What interventions are being tested in trial NCT05107466?
The interventions under investigation include: P300 Visually evoked potential (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05107466?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05107466 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
RECRUITING · Phase 1
-
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.